<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>AnyAD: Unified Any-Modality Anomaly Detection in Incomplete Multi-Sequence MRI - Health AI Hub</title>
    <meta name="description" content="This paper introduces AnyAD, a unified framework for robust anomaly detection and localization in brain MRI, specifically addressing the challenge of missing im">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>AnyAD: Unified Any-Modality Anomaly Detection in Incomplete Multi-Sequence MRI</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.21264v1" target="_blank">2512.21264v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-24
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Changwei Wu, Yifei Chen, Yuxin Du, Mingxuan Liu, Jinying Zong, Beining Wu, Jie Dong, Feiwei Qin, Yunkang Cao, Qiyuan Tian
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.21264v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.21264v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces AnyAD, a unified framework for robust anomaly detection and localization in brain MRI, specifically addressing the challenge of missing imaging modalities and scarce abnormal data in clinical workflows. By integrating a dual-pathway DINOv2 encoder with feature alignment and a novel INP-guided decoder, AnyAD effectively adapts to arbitrary modality availability without re-training. The model demonstrates superior generalization and performance over state-of-the-art baselines across various modality combinations and datasets.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to medical imaging and diagnostics, as it provides a robust solution for detecting anomalies in brain MRI even when key sequences are missing, a common occurrence in clinical practice. It enhances diagnostic capabilities by enabling reliable AI analysis under suboptimal data conditions, crucial for areas like neuro-oncology and general neurology.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is a robust, 'any-modality' anomaly detection and localization system for brain MRI. It aims to assist radiologists in identifying abnormal patterns (e.g., tumors, lesions, or other pathologies) in brain scans, even when certain MRI sequences are missing or incomplete. This can lead to more accurate and efficient diagnosis, reducing the need for repetitive training or re-scans in clinical settings, and ultimately improving patient care by enhancing the detection of critical neurological conditions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical challenge of reliable anomaly detection in brain MRI, compounded by scarce annotated abnormal cases and frequent absence of key imaging modalities in clinical settings.</li>
                    
                    <li>Presents AnyAD, a unified 'Any-Modality' anomaly detection framework designed for robust performance under arbitrary MRI modality availability and capable of anomaly localization.</li>
                    
                    <li>Employs a dual-pathway DINOv2 encoder coupled with a feature distribution alignment mechanism to statistically align incomplete-modality features with full-modality representations, ensuring stable inference during severe modality dropout.</li>
                    
                    <li>Introduces an Intrinsic Normal Prototypes (INPs) extractor and an INP-guided decoder that specifically reconstruct normal anatomical patterns, thereby naturally amplifying and highlighting abnormal deviations.</li>
                    
                    <li>Learns to adapt to all possible modality configurations through randomized modality masking and indirect feature completion during the training phase, eliminating the need for repetitive training for different modality sets.</li>
                    
                    <li>Achieves superior performance, consistently surpassing state-of-the-art industrial and medical anomaly detection baselines across 7 distinct modality combinations on three diverse brain MRI datasets (BraTS2018, MU-Glioma-Post, and Pretreat-MetsToBrain-Masks).</li>
                    
                    <li>Establishes a scalable and generalized paradigm for multimodal medical anomaly detection, applicable in real-world clinical scenarios characterized by imperfect and incomplete data conditions.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The AnyAD framework integrates a dual-pathway DINOv2 encoder for feature extraction. A key component is the feature distribution alignment mechanism, which statistically normalizes features from incomplete modality sets to match full-modality representations. It also incorporates an Intrinsic Normal Prototypes (INPs) extractor and an INP-guided decoder. The decoder is designed to reconstruct only normal anatomical patterns, thereby highlighting anomalies. Training involves randomized modality masking and indirect feature completion to teach the model adaptability to all modality configurations without requiring re-training.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The proposed AnyAD approach consistently outperforms existing state-of-the-art industrial and medical anomaly detection baselines across 7 different MRI modality combinations. It demonstrates superior generalization capabilities on diverse brain MRI datasets, including BraTS2018, MU-Glioma-Post, and Pretreat-MetsToBrain-Masks, successfully performing robust anomaly detection and localization even with significant modality dropout.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This study has significant clinical impact by enabling reliable, AI-driven anomaly detection in brain MRI despite common practical limitations like missing scan sequences. It can streamline clinical workflows, potentially reducing the need for repeat scans or complex manual image interpretation in cases of incomplete data. This could lead to earlier and more accurate diagnosis of brain pathologies, ultimately improving patient care and outcomes in neuro-radiology and oncology.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly stated in the abstract.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly stated in the abstract.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neuroimaging</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Neurology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Anomaly Detection</span>
                    
                    <span class="tag tag-keyword">Brain MRI</span>
                    
                    <span class="tag tag-keyword">Multi-modality</span>
                    
                    <span class="tag tag-keyword">Incomplete Data</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">DINOv2</span>
                    
                    <span class="tag tag-keyword">Clinical Workflow</span>
                    
                    <span class="tag tag-keyword">Generalization</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Reliable anomaly detection in brain MRI remains challenging due to the scarcity of annotated abnormal cases and the frequent absence of key imaging modalities in real clinical workflows. Existing single-class or multi-class anomaly detection (AD) models typically rely on fixed modality configurations, require repetitive training, or fail to generalize to unseen modality combinations, limiting their clinical scalability. In this work, we present a unified Any-Modality AD framework that performs robust anomaly detection and localization under arbitrary MRI modality availability. The framework integrates a dual-pathway DINOv2 encoder with a feature distribution alignment mechanism that statistically aligns incomplete-modality features with full-modality representations, enabling stable inference even with severe modality dropout. To further enhance semantic consistency, we introduce an Intrinsic Normal Prototypes (INPs) extractor and an INP-guided decoder that reconstruct only normal anatomical patterns while naturally amplifying abnormal deviations. Through randomized modality masking and indirect feature completion during training, the model learns to adapt to all modality configurations without re-training. Extensive experiments on BraTS2018, MU-Glioma-Post, and Pretreat-MetsToBrain-Masks demonstrate that our approach consistently surpasses state-of-the-art industrial and medical AD baselines across 7 modality combinations, achieving superior generalization. This study establishes a scalable paradigm for multimodal medical AD under real-world, imperfect modality conditions. Our source code is available at https://github.com/wuchangw/AnyAD.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>15 pages, 8 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>